1 week ago
GSK (GSK) Stock Gains Following Berenberg Analyst Upgrade and $750M Chimagen Acquisition
GSK stock increased 0.4% following Berenberg's upgrade to buy with £22 target and announcement of $750M Chimagen deal for multiple myeloma therapy.
The post GSK (GSK) Stock Gains Following Berenberg Analyst Upgrade and $750M Chimagen Acquisition appeared first on Blockonomi.
Source: Blockonomi →Related News
- 2 minutes ago
Ondas (ONDS) Stock Climbs on $56M Triple Defense Technology Acquisition
- 9 minutes ago
Apple (AAPL) Stock Retreats Following Record-Breaking Peak Driven by iPhone Mome...
- 16 minutes ago
Markets Tumble as Treasury Yields Break Through 5% Barrier
- 24 minutes ago
Micron Technology (MU) Target Lifted to $1,300 by Citi on Memory Market Strength
- 25 minutes ago
HSBC Maintains Maximum Bullish Stance on Equities with Tech as Leading Choice